Literature DB >> 10545712

Pathology report in colon cancer: what is prognostically important?

C C Compton1.   

Abstract

Surgical resection is the primary treatment modality for colorectal cancer, and the most powerful tool for assessing prognosis following surgery is pathologic analysis of the resection specimen. Although the parameters that determine the pathologic stage are the strongest predictors of postoperative outcome, a number of additional pathologic features have prognostic significance that is independent of stage. These include: histologic grade; small vessel (lymphatic or venular) invasion; extramural venous invasion; perineural invasion; tumor border configuration; host lymphoid response to tumor, and the status of surgical margins. For specimens in which the radial (circumferential) margin is applicable, surgical clearance around the tumor is also of import. It is self-evident that, compared to data derived from additional assays, prognostic information that can be derived directly from standard histologic sections of a tumor is of the greatest cost-benefit to the patient. In the current era of cost containment, it is essential that surgical pathologists evaluate and report the pathologic features that are of prognostic and/or predictive significance in every case of colorectal cancer and, in turn, that the import of these be understood by the treating physicians.

Entities:  

Mesh:

Year:  1999        PMID: 10545712     DOI: 10.1159/000016908

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  16 in total

Review 1.  The ins and outs of molecular pathology reporting.

Authors:  Véronique Tack; Kelly Dufraing; Zandra C Deans; Han J van Krieken; Elisabeth M C Dequeker
Journal:  Virchows Arch       Date:  2017-03-26       Impact factor: 4.064

2.  Prognostic value of mucin 4 expression in colorectal adenocarcinomas.

Authors:  Chandrakumar Shanmugam; Nirag C Jhala; Venkat R Katkoori; Wen Wan; Sreelatha Meleth; William E Grizzle; Upender Manne
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

Review 3.  Prognostic biomarkers in colorectal cancer: where do we stand?

Authors:  Xavier Sagaert
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 4.  Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond.

Authors:  Azah A Althumairi; Susan L Gearhart
Journal:  J Gastrointest Oncol       Date:  2015-06

Review 5.  [Clinical, pathological and molecular prognostic factors in colorectal carcinomas].

Authors:  S E Baldus
Journal:  Pathologe       Date:  2003-01-21       Impact factor: 1.011

Review 6.  Adjuvant therapy for colon cancer.

Authors:  Olivia Aranha; Al B Benson
Journal:  Curr Gastroenterol Rep       Date:  2007-10

7.  The pathologist's role in rectal cancer patient assessments.

Authors:  Joseph E Willis
Journal:  Clin Colon Rectal Surg       Date:  2007-08

8.  Perineural invasion is an independent predictor of outcome in colorectal cancer.

Authors:  Catherine Liebig; Gustavo Ayala; Jonathan Wilks; Gordana Verstovsek; Hao Liu; Neeti Agarwal; David H Berger; Daniel Albo
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

9.  Colorectal carcinoma: Pathologic aspects.

Authors:  Matthew Fleming; Sreelakshmi Ravula; Sergei F Tatishchev; Hanlin L Wang
Journal:  J Gastrointest Oncol       Date:  2012-09

10.  Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.

Authors:  Ryota Nakanishi; Jun Harada; Munkhbold Tuul; Yan Zhao; Koji Ando; Hiroshi Saeki; Eiji Oki; Takefumi Ohga; Hiroyuki Kitao; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2012-11-29       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.